Edition:
United Kingdom

People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

61.81USD
17 May 2019
Change (% chg)

$-1.97 (-3.09%)
Prev Close
$63.78
Open
$63.14
Day's High
$65.00
Day's Low
$61.00
Volume
99,778
Avg. Vol
132,376
52-wk High
$65.55
52-wk Low
$29.17

Gentile, Kimberly 

Ms. Kimberly Gentile serves as Vice President - Clinical Operations of the Company. Before coming to Biohaven, Ms. Gentile served as associate director, project manager, global clinical operations at BMS from 2000 to February 2014. Prior to this, she was a senior clinical trial manager at SCIREX Corporation from 1996 to June 2000. Ms. Gentile received her B.S. in Psychology from Salem State University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Declan Doogan

247,770

Vlad Coric

3,855,660

James Engelhart

2,510,280

Charles Conway

1,626,150

Kimberly Gentile

--

Robert Berman

521,060
As Of  31 Dec 2017